| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $3.9M | -76.3% |
| SG&A Expense | $13.5M | -41.9% |
| Operating Income | -$17.5M | -220.0% |
| Pre-tax Income | -$15.9M | -189.7% |
| Income Tax | $0 | — |
| Net Income | -$15.9M | -189.7% |
| EPS (Basic) | -$2.39 | -189.5% |
| EPS (Diluted) | -$2.39 |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.0M | +386.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $0 | — |
| Current Assets | $18.3M | -55.1% |
| Total Assets | $18.3M | -55.8% |
| Current Liabilities | $1.4M | -83.8% |
| Total Liabilities | $1.4M | -83.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.8M | +58.7% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $35.1M | -28.5% |
| Financing Cash Flow | $0 | +100.0% |
| Free Cash Flow | -$20.8M | +58.7% |
| -189.5% |
| Stockholders' Equity |
| $16.9M |
| -48.7% |